Delivery Order SPE2DB22D1106-SPE2DB25FFEL1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,092.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.99 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on June 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by June 27, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication used to improve blood sugar control in...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication used to improve blood sugar control in...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a commonly prescribed diabetes medication used to improve blood sugar control in...
- The Defense Logistics Agency awarded a delivery order valued at $1,166.88 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems supported by the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $24,668.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on May 7, 2025, with an ultimate completion date of May 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a prescription diabetes medication used for managing type 2 diabetes and cardiovascular...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes management pharmaceutical used to improve blood sugar control in patients...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a delivery order valued at $6,691.77 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a $10,038.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEL1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens valued at $6,247.10 on August 20, 2025. This firm fixed-price delivery order, which is due for completion by August 21, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a prescription diabetes medication commonly used to improve blood sugar control in patients with type 2 diabetes. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026. As a prime vendor for federal military and healthcare procurement, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent award of competitively bid delivery orders demonstrates its critical role in the federal medical supply chain and its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 8/20/25 |